MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Assertio Holdings Operating Expenses 2011-2025 | ASRT
Annual Operating Expenses Assertio Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 133 M | 221 M | 229 M | 337 M | 344 M | 355 M | 138 M | 118 M | 115 M | 96.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 355 M | 96.7 M | 209 M |
Operating Expenses of other stocks in the Drug manufacturers industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Canopy Growth Corporation
CGC
|
197 M | $ 1.69 | -3.16 % | $ 182 M |  Canada |
 |
Alimera Sciences
ALIM
|
71.8 M | - | - | $ 142 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
213 M | - | - | $ 754 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
40.3 M | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
38.9 M | - | 0.86 % | $ 117 M | USA |
 |
Cronos Group
CRON
|
154 M | $ 3.05 | -6.72 % | $ 1.63 B | Canada |
 |
Agile Therapeutics
AGRX
|
30.5 M | - | 10.11 % | $ 58.2 M | USA |
 |
Aurora Cannabis
ACB
|
183 M | $ 5.17 | -4.22 % | $ 86.3 M | Canada |
 |
Catalent
CTLT
|
512 M | - | - | $ 11.5 B | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
213 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
106 M | - | 2.45 % | $ 38.1 M | Canada |
 |
DURECT Corporation
DRRX
|
44.6 M | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
113 M | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
368 M | $ 4.78 | -0.83 % | $ 629 M | USA |
 |
Endo International plc
ENDP
|
763 M | - | - | $ 28.9 M |  Irlanda |
 |
Emergent BioSolutions
EBS
|
558 M | $ 12.03 | 5.34 % | $ 616 M | USA |
 |
Pacira BioSciences
PCRX
|
279 M | $ 26.7 | 1.56 % | $ 1.23 B | USA |
 |
Evoke Pharma
EVOK
|
12.6 M | $ 10.97 | 0.18 % | $ 36.7 M | USA |
 |
Athenex
ATNX
|
96.7 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
196 M | $ 21.39 | 0.14 % | $ 2.04 B |  France |
 |
Rockwell Medical
RMTI
|
31.1 M | $ 0.87 | -5.71 % | $ 20.3 M | USA |
 |
Evolus
EOLS
|
107 M | $ 7.18 | 1.92 % | $ 445 M | USA |
 |
Harrow Health
HROW
|
90.1 M | $ 45.82 | -2.64 % | $ 1.49 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
9.18 M | $ 3.51 | -2.11 % | $ 4.36 M | USA |
 |
China Pharma Holdings
CPHI
|
2.6 M | $ 1.55 | -0.26 % | $ 27.1 M |  China |
 |
Bausch Health Companies
BHC
|
4.96 B | $ 6.88 | -0.65 % | $ 2.51 B | Canada |
 |
Veru
VERU
|
44 M | $ 2.44 | 0.83 % | $ 329 M | USA |
 |
Lannett Company
LCI
|
209 M | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
41.4 M | $ 1.8 | -6.51 % | $ 402 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
35.2 M | $ 3.05 | 20.47 % | $ 42.9 M | USA |
 |
cbdMD
YCBD
|
28.9 M | $ 1.39 | 13.52 % | $ 5.99 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
55.6 M | - | - | $ 193 M | Canada |
 |
Solid Biosciences
SLDB
|
130 M | $ 5.81 | -1.11 % | $ 237 M | USA |
 |
PetIQ
PETQ
|
138 M | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
104 M | $ 4.32 | 6.4 % | $ 130 M | USA |
 |
Jupiter Wellness
JUPW
|
39.6 M | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
1.43 B | $ 12.86 | -2.17 % | $ 1.77 B | USA |
 |
ProPhase Labs
PRPH
|
47.1 M | $ 0.12 | 0.17 % | $ 1.9 M | USA |
 |
Radius Health
RDUS
|
304 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
22.5 M | - | -4.76 % | $ 65.3 M | USA |
 |
Sundial Growers
SNDL
|
102 K | $ 1.96 | -11.31 % | $ 3.37 M | Canada |
 |
OptiNose
OPTN
|
129 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
44.2 M | - | -27.8 % | $ 2.56 M | USA |
 |
SCYNEXIS
SCYX
|
67.5 M | $ 0.64 | -1.25 % | $ 30.6 M | USA |
 |
Tricida
TCDA
|
153 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
1.52 B | $ 11.6 | -4.56 % | $ 7.17 B | Canada |
 |
TherapeuticsMD
TXMD
|
9.82 M | $ 1.69 | -3.43 % | $ 17.6 M | USA |
 |
Zomedica Corp.
ZOM
|
14.1 M | - | -0.21 % | $ 98 M | USA |
 |
Viatris
VTRS
|
4.88 B | $ 11.66 | 0.09 % | $ 14.1 B | USA |